COVID-19 pneumonia and ominous methemoglobinemia: Causation or confounding
Severe COVID-19 pneumonia and methemoglobinemia share many presenting clinical features, and it is unclear whether this may have been predominantly due to a dramatic increase in the use of oxidizing medications, which were used to treat COVID-19 during the pandemic, or COVID-19 itself. Initial correct assessment is sometimes difficult, particularly if the clinical judgment has been confounded towards the emerging disease. To highlight such a dilemma, we report a case of COVID-19 pneumonia and concomitant significant methemoglobinemia to raise awareness of the emergence of methemoglobinemia amidst the COVID-19 pandemic.
Other Information
Published in: IDCases
License: http://creativecommons.org/licenses/by/4.0/
See article on publisher's website: https://dx.doi.org/10.1016/j.idcr.2023.e01705
Funding
Open Access funding provided by the Qatar National Library.
History
Language
- English
Publisher
ElsevierPublication Year
- 2023
License statement
This Item is licensed under the Creative Commons Attribution 4.0 International License.Institution affiliated with
- Hamad Medical Corporation
- Communicable Disease Center - HMC
